Home › NDC Lookup › RxCUI directory › RxCUI 861134

24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet [UroXatral] — RxCUI 861134

RxNorm drug concept · Semantic branded drug
RxCUI 861134 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861134
Official name24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet [UroXatral]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR UroXatral 10 MG Extended Release Oral Tablet; Uroxatral 10 MG 24HR Extended Release Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Alfuzosin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's designed to relax the muscles around your prostate and the outlet of your bladder. When those muscles loosen up, urine can flow more easily. Most men notice improvements in sy...
  • What exactly is alfuzosin supposed to do for me?
  • Yes, this one really does matter. Taking alfuzosin without food reduces the amount your body absorbs by about half, which means it won't work as well. Try to take it with the same...
  • Does it matter if I take it with food? What if I forget to eat?
📖 Read our full Alfuzosin guide →

🕸️ Concept Web — How 24 HR alfuzosin hydrochloride 10 MG Extended Rel... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet [UroXatral] RxCUI 861134

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Alfuzosin 17300
    • Alfuzosin hydrochloride 46043
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • UroXatral 356728
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Alfuzosin Extended Release Oral Tablet 370798
    • Alfuzosin hydrochloride Extended Release Oral Tablet 2649232
    • Alfuzosin Oral Product 1164267
    • Alfuzosin Pill 1164268
    • Alfuzosin hydrochloride Oral Product 2660396
    • Alfuzosin hydrochloride Pill 2661004
    • Alfuzosin Extended Release Oral Tablet [UroXatral] 406325
    • Alfuzosin hydrochloride Extended Release Oral Tablet [UroXatral] 2654872
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet SCD · 861132
  • Alfuzosin hydrochloride 10 MG SCDC · 861131
  • Alfuzosin Extended Release Oral Tablet SCDF · 370798
  • Alfuzosin hydrochloride Extended Release Oral Tablet SCDFP · 2649232
  • Alfuzosin Oral Product SCDG · 1164267
  • Alfuzosin Pill SCDG · 1164268
  • Alfuzosin hydrochloride Oral Product SCDGP · 2660396
  • Alfuzosin hydrochloride Pill SCDGP · 2661004

Brand-Name Concepts

  • Alfuzosin hydrochloride 10 MG [UroXatral] SBDC · 861133
  • Alfuzosin Extended Release Oral Tablet [UroXatral] SBDF · 406325
  • Alfuzosin hydrochloride Extended Release Oral Tablet [UroXatral] SBDFP · 2654872
  • UroXatral Oral Product SBDG · 1186759
  • UroXatral Pill SBDG · 1186760
  • UroXatral BN · 356728

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 861134 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59212-0200-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-10) Uroxatral Advanz Pharma (US) Corp. 2013-06-03
59212-0200-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-30) Uroxatral Advanz Pharma (US) Corp. 2019-01-18
Observed labelers: Advanz Pharma (US) Corp. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.